Oral Dydrogesterone Treatment During the First Trimester of Pregnancy in Women With Recurrent Miscarriage: A Double-Blind, Prospectively Randomized, Placebo-Controlled, Parallel Group Trial.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Dydrogesterone (Primary)
- Indications Pregnancy; Spontaneous abortion
- Focus Biomarker; Therapeutic Use
- 26 Aug 2011 Biomarkers information updated
- 25 Aug 2011 Additional lead trial centre, investigator (Guenter Krause) identified as reported by ClinicalTrials.gov.
- 25 Aug 2011 Company added as reported by ClinicalTrials.gov.